<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5283585 Figure_1-A</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Dose-response relationship between icv LPS injection and mice weight loss (n=6 to 12). Data are expressed as means &#177; SEM. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, color-coded asterisks indicate a significant difference from the experimental condition assigned to the respective color-coded curve.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_1-B</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B, C. Analysis by real-time PCR Arrays of interleukins, cytokines (B) gene expression in the hypothalamus 6h after an acute icv injection of LPS vs saline in WT mice (n=6 per group). LPS-induced fold up-regulation vs saline condition was calculated using the &#916;&#916;CT method according to the manufacturer's protocol.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_1-C</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C. Analysis by real-time PCR Arrays of CC chemokine ligands and receptors (C) gene expression in the hypothalamus 6h after an acute icv injection of LPS vs saline in WT mice (n=6 per group). LPS-induced fold up-regulation vs saline condition was calculated using the &#916;&#916;CT method according to the manufacturer's protocol.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_2-A</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. % of weight variation compared to initial body weight at different times (from 2 to 48h) after acute icv injection of saline (black curve), INCB3344 (grey curve), LPS (red curve) or LPS+INCB3344 (blue curve) in WT mice (n=6 to 12).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_2-B</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Fold increase in weight-loss compare to appropriate saline injected control 26h after acute icv injection of LPS (red bar) or LPS+INCB3344 (blue bar) in WT mice or LPS in CCR2 KO mice (striped bar) (n=6).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_2-C</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Fold increase in weight-loss compare to appropriate saline injected control 26h after acute icv injection of CCL2 in WT mice (orange bar) or in CCR2 KO mice (striped bar) (n=6).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_2-D-E</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 2-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, F. Variation of food intake (D) recorded for 45h during light and dark period (grey area) after acute icv injection of saline (black curve), LPS (red curve) or LPS+INCB3344 (blue curve) in WT mice (n=5-8). E, G. Food intake (E) average over 4 periods of 12 hours after acute icv injection of saline (black bars), LPS (red bars) or LPS+INCB3344 (blue bars) in WT mice (n=5-8).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_2-F-G</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 2-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>D, F. Fat oxidation (F) recorded for 45h during light and dark period (grey area) after acute icv injection of saline (black curve), LPS (red curve) or LPS+INCB3344 (blue curve) in WT mice (n=5-8). E, G. Fat oxidation (G) average over 4 periods of 12 hours after acute icv injection of saline (black bars), LPS (red bars) or LPS+INCB3344 (blue bars) in WT mice (n=5-8).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_3-A</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Real-time PCR analysis of the genes coding for the pro-inflammatory cytokines IL-1&#946;, IL-6, TNF-&#945; in the hypothalamus of icv LPS injected mice at different times after injection (from 1h to 18h), normalized to values in icv saline injected mice (n=6 per group).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_3-B</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B-E. Study of gene and protein hypothalamic expression of the chemokine CCL2 (B, C) in icv LPS injected mice. Real-time PCR analysis for CCL2 (B) at different times after injection (from 1h to 24h), normalized to values in control icv saline injected mice (n=6 per group).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_3-C</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>B-E. Study of gene and protein hypothalamic expression of the chemokine CCL2 (B, C) in icv LPS injected mice. at different times after injection (from 1h to 24h), normalized to values in control icv saline injected mice (n=6 per group). Measurement of CCL2 (C) ) concentration by EIA after icv LPS injection (black bars) or icv saline injection (grey bars) in mice at 1h, 6h and 18h after injection.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_3-D</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>B-E. Study of gene and protein hypothalamic expression of the MCH peptide (D, E) in icv LPS injected mice. Real-time PCR analysis for MCH (D) at different times after injection (from 1h to 24h), normalized to values in control icv saline injected mice (n=6 per group).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_3-E</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>B-E. Study of gene and protein hypothalamic expression of MCH peptide (D, E) in icv LPS injected mice. Measurement of MCH (E) concentration by EIA after icv LPS injection (black bars) or icv saline injection (grey bars) in mice at 1h, 6h and 18h after injection. Cerebellum was used as negative control (3 independent experiments, n=6 per group in each experiment).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_3-F</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. The decrease in MCH mRNA levels observed 18h after icv LPS injection is partly abolished by the CCR2 antagonist INCB3344 (10&#956;M) and in CCR2 KO mice, as shown by real-time PCR analysis for MCH in the hypothalamus. Results were normalized to values in icv saline injected WT mice (n=6 per group). Data are expressed as means &#177; SEM. ** or $$ p&lt;0.01. * saline vs icv LPS injection in WT mice. $ icv LPS injection in WT mice vs LPS+INCB3344 icv injection in WT mice or icv LPS injection in CCR2 KO mice.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_4-A</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Real-time PCR analysis of the genes coding for the pro-inflammatory cytokines IL-1&#946;, IL-6, TNF-&#945; in the hypothalamus of icv CCL2 injected mice at different times after injection (from 1h to 18h), normalized to values in icv saline injected mice (n = 6 per group).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_4-B</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B-E. Study of gene and protein hypothalamic expression of the chemokine CCL2 (B, C) in icv CCL2 injected mice. Real-time PCR analysis for CCL2 (B) at different times after injection (from 1h to 24h), normalized to values in control icv saline injected mice (n = 6 per group).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_4-C</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>B-E. Study of gene and protein hypothalamic expression of the chemokine CCL2 (B, C) in icv CCL2 injected mice. Measurement of CCL2 (C) concentration by EIA after icv CCL2 injection (black bars) or icv saline injection (grey bars) in mice at 1h, 6h and 18h after injection.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_4-D</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>B-E. Study of gene and protein hypothalamic expression of MCH peptide (D, E) in icv CCL2 injected mice. Real-time PCR analysis for MCH (D) at different times after injection (from 1h to 24h), normalized to values in control icv saline injected mice (n = 6 per group).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_4-E</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>B-E. Study of gene and protein hypothalamic expression of MCH peptide (D, E) in icv CCL2 injected mice. Measurement of MCH (E) concentration by EIA after icv CCL2 injection (black bars) or icv saline injection (grey bars) in mice at 1h, 6h and 18h after injection. Cerebellum was used as negative control (3 independent experiments, n=6 per group in each experiment).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_4-F</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. The decrease in MCH mRNA levels observed 18h after icv CCL2 injection is abolished by the CCR2 antagonist INCB3344 (10&#956;M) and in CCR2 KO mice, as shown by real-time PCR analysis for MCH in the hypothalamus. Results were normalized to values in icv saline injected WT mice (n=6 per group). Data are expressed as means &#177; SEM. ** or $$ p&lt;0.01. * saline vs icv CCL2 injection in WT mice. $ icv CCL2 injection in WT mice vs CCL2+INCB3344 icv injection in WT mice or icv CCL2 injection in CCR2 KO mice.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_5-A</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Colocalization of MCH and the receptor for CCL2 (CCR2) in the LHA of mice expressing CFP under the promoter of MCH. The overlap of MCH and CCR2 immunoreactivity indicates that CCR2 is expressed on MCH neurons in the LHA.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_5-B</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B, D. CCL2 effects on MCH neurons of MCH-CFP knock-in mice recorded in current-clamp mode. Representative trace of the effects of CCL2 on MCH neurons (B). The CCR2 antagonist INCB3344 prevents the small hyperpolarization of MCH neurons elicited by CCL2.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_5-C</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>Effects of CCL2 at various concentrations, alone or in the presence of the INCB3344 (1&#181;M) or barium (200&#181;M) on the membrane potential of MCH neurons (n= 5 to 16) (C).</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_5-D</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>B, D. CCL2 effects on MCH neurons of MCH-CFP knock-in mice recorded in current-clamp mode. Representative trace of the effects of CCL2 on MCH neurons Discharge pattern of two representative MCH neurons in response to a depolarizing current pulse injection (current pulses applied every 10s) in control condition and in the presence of CCL2 (D). The control trace is recorded just before the application of CCL2 while the CCL2 trace is recorded 1 min after the beginning of CCL2 application. CCL2 delayed the third action potential (left panel) and induced failures in the action potential evoked in the right panel.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_5-E</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Effect of CCL2 on KCl-induced MCH release. The perifusion of hypothalamic tissues with 60mM KCl for 30 min induces an up to 3.1-fold increase in MCH release. CCL2 (100 nM) dramatically blunts KCl-induced MCH release, an effect partially by the addition of INCB3344 (10&#181;M) (3 to 5 independent experiments, 3 chambers per condition in each experiment). * or $ p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001. * KCl vs KCl+CCL2 conditions. $ KCl+CCL2 vs KCl+CCL2+INCB3344 conditions. Data are expressed as mean fold-increase in MCH release per chamber vs basal secretion, &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283585 Figure_5-F</id>
    <infon key="sourcedata_document">2305</infon>
    <infon key="doi">10.15252/embr.201541499</infon>
    <infon key="pmc_id">5283585</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Effect on MCH-R1 antagonist on LPS- and CCL2-induced weight loss. Data are expressed in mean % of weight variation compared to initial body weight at different times (from 2 to 48h) after acute icv injection of saline (black bar), H6408 (dark blue bar), LPS (red bar), or LPS+H6408 (light red bar), CCL2 (orange bar), CCL2+H6408 (yellow bar) in WT mice (n=3 to 12). Data are expressed as means &#177; SEM. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, color-coded asterisks indicate a significant difference from the experimental condition assigned to the respective color-coded bar.</text>
    </passage>
  </document>
</collection>
